Stay Updated
Press Releases
STATEMENT: CMS Announces 15 Drugs Selected for Round 3 of Medicare Drug Price Negotiation
Drugs included in Round 3 are used by nearly 1.8 million people on Medicare and accounted for $27 billion in Medicare spending WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has released the list of the next 15 high-priced medications selected for Medicare Drug Price Negotiation, along with one drug selected for […]
Press Releases
Remembering David Mitchell: A Distinguished Life In Service to Others
WASHINGTON, D.C. — Today, we honor the life, legacy, and friendship of David Mitchell – a tireless public health leader and the founder of Patients For Affordable Drugs – who died on Friday, January 2, 2026. Below is a statement from Chuck Hurley, David’s great friend and Board Chair of Patients For Affordable Drugs, reflecting on […]
Press Releases
WASHINGTON, D.C. — The Solicitor General’s office filed a brief urging the Supreme Court to deny AstraZeneca’s petition challenging the constitutionality of the Medicare Negotiation Program, forcefully defending the program and rejecting the drugmaker’s claims outright. The filing responds to AstraZeneca’s effort to overturn a 2024 appeals court ruling that upheld the program. The petition […]
Press Releases
Medicare’s First Negotiated Drug Prices Take Effect: a Win for Patients
Patients on Medicare begin seeing an average list price reduction of 63% percent on the first 10 blockbuster drugs starting January 1st WASHINGTON, D.C. — Today marks a historic milestone for prescription drug affordability in the United States. For the first time in Medicare’s history, lower negotiated prices for 10 of the most expensive and widely used prescription […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs has released the following statement on the retirement of its Founder and President of the Board, David Mitchell. “After 15 years living with cancer and in continuous treatment, David Mitchell is stepping down as President of the Board and retiring from Patients For Affordable Drugs to focus on his health […]
Press Releases
WASHINGTON, D.C. — Today, the U.S. District Court for the District of Columbia rejected Teva Pharmaceuticals’ challenge to the Medicare Drug Price Negotiation Program — marking the 16th defeat against the industry’s nationwide legal campaign to prevent the law from lowering prices. Teva manufactures Austedo and Austedo XR — used to treat involuntary movements associated […]
Press Releases
Pharma’s Losing Streak In Court Continues: Novo Nordisk’s Appeal Rejected
Bipartisan panel of judges unanimously rejects industry’s recycled arguments as lower drug prices draw closer for millions of patients WASHINGTON, D.C. — In yet another blow to Big Pharma’s nationwide legal campaign against Medicare Negotiation, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novo Nordisk’s challenge to the program this morning — marking the 15th legal defeat for […]
Press Releases
Countering PhRMA’s legal claims, P4AD continues to defend the historic Medicare Negotiation Program by amplifying the experiences of patients with high drug prices. WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed its fifth patient-centered amicus brief defending the Medicare Negotiation Program – this time in the Fifth Circuit Court of Appeals, where PhRMA […]